(Press-News.org) ATS 2012, SAN FRANCISCO - Treatment of obstructive sleep apnea (OSA) in children normalizes disturbances in the neuronal network responsible for attention and executive function, according to a new study.
"OSA is known to be associated with deficits in attention, cognition, and executive function," said lead author Ann Halbower, MD, Associate Professor at the Children's Hospital Sleep Center and University of Colorado Denver. "Our study is the first to show that treatment of OSA in children can reverse neuronal brain injury, correlated with improvements in attention and verbal memory in these patients."
The results will be presented at the ATS 2012 International Conference in San Francisco.
In the study, children (ages 8-11) with moderate-severe OSA were compared to healthy controls. Brain imaging with magnetic resonance spectroscopy imaging was performed at baseline in 15 OSA patients and seven controls, along with neuropsychological testing. OSA treatment consisted of adenotonsillectomy followed by monitored continuous positive airway pressure (CPAP) or nasal treatments. Brain imaging and neuropsychological testing was performed again in 11 OSA patients and the seven controls six months after treatment.
Compared with controls at baseline, children with OSA exhibited significantly decreased N-acetyl aspartate to choline ratios (NAA/Cho) in the left hippocampus and left frontal cortex, along with significant decreases in the executive functions of verbal memory, and attention. Following treatment, both left and right frontal cortex neuronal metabolites normalized, and hippocampal metabolites improved with a medium effect size (0.5).
More complete reversal of hippocampal abnormalities was seen in children with milder OSA when apnea-hypopnea index (AHI) improved (although this is very preliminary data). Verbal memory and attention improved with medium to large effect sizes. Improvements in attention and verbal memory were correlated with normalization of NAA/Cho in the right and left frontal cortex (p=0.5).
"We have demonstrated for the first time that treatment of OSA in children normalizes brain metabolites in portions of the neuronal network responsible for attention and executive function," concluded Dr. Halbower. "We speculate that if OSA is treated earlier, there may be a more brisk improvement in the hippocampus, a relay station for executive function, learning, and memory."
"Our results point to the importance of early diagnosis and treatment of OSA in children, as it could potentially have profound effects on their development."
###
"Brain Injury And Cognitive Deficits Reverse With Treatment Of Childhood Obstructive Sleep Apnea" (Session A19, Sunday, May 20, 10:15 a.m., Room 2020-2022, Moscone Center; Abstract 33865)
* Please note that numbers in this release may differ slightly from those in the abstract. Many of these investigations are ongoing; the release represents the most up-to-date data available at press time.
Abstract 33865
Brain Injury And Cognitive Deficits Reverse With Treatment Of Childhood Obstructive Sleep Apnea
Type: Late Breaking Abstract
Category: 14.04 - Pediatric Sleep and Control of Breathing (PEDS/SRN)
Authors: A.C. Halbower1, J. Janusz1, M. Brown2, J. Strain1, N. Friedman2, F. Accurso1, P.L. Smith3; 1Children's Hospital Colorado and University of Colorado Denver - Aurora, CO/US, 2University of Colorado Denver - Aurora/US, 3Johns Hopkins University - Baltimore/US
Abstract Body
Introduction : To determine the reversibility of brain neuronal abnormalities with treatment of Pediatric Obstructive Sleep Apnea (OSA), OSA patients were compared to healthy controls (HC) matched by age, gender, race, and SES. We hypothesized that neuronal alterations of the hippocampus and frontal cortex associated with childhood sleep-disordered breathing would reverse with treatment.
Methods : OSA patients (N=17) and healthy controls (N=11) age 8-11 years, Tanner stage I-II, underwent neuropsychological tests spanning 7 domains. Magnetic resonance spectroscopy imaging of the brain was performed in 15 OSA and 7 HC. OSA patients underwent Adenotonsillectomy followed by monitored CPAP if AHI>3, or nasal treatments if AHI 2-3. Six months after treatment, 11 OSA patients returned for brain imaging and neuropsychological tests compared to HC.
Results : Results: Children were mean age 10 yr, 55% male, 50% Hispanic, 20% AA. Mean OAHI for OSA patients = 13.6, for HC =0.3. Confirming our previous findings, N-acetyl aspartate to choline ratios (NAA/Cho) in the left hippocampus and left frontal cortex were significantly decreased in OSA patients compared to HC (p=0.03 and 0.04 respectively). OSA patients had a significant decrease in the executive function of working memory (p= 0.00), attention (p=0.00) and verbal memory (p=0.02). After treatment, both left and right frontal cortex neuronal metabolites normalized (p= 0.03) while the hippocampal metabolites did not. Verbal memory improved (p=0.04) and improvements in attention were correlated with the normalization of NAA/Cho in the frontal lobes (r=0.67, p=0.05).
Conclusion: Conclusion: This is the first study demonstrating that brain metabolites of the neuronal network responsible for attention and executive function, the frontal cortex, normalize with treatment of pediatric OSA. Improvements in attention were correlated with the normalization of metabolites in the frontal lobes. We speculate that earlier diagnosis and treatment of childhood OSA may improve the trajectory of development, thus implying the need to identify these patients and expedite management.
Funded by: National Institutes of Health, National Center for Research Resources
Treatment of childhood OSA reverses brain abnormalities
2012-05-21
ELSE PRESS RELEASES FROM THIS DATE:
Prenatal exposure to pollution especially dangerous for children with asthma
2012-05-21
ATS 2012, SAN FRANCISCO – The link between prenatal exposure to air pollution and childhood lung growth and respiratory ailments has been established by several studies in recent years, and now a new study suggests that these prenatal exposures can be especially serious for children with asthma.
The study will be presented at the ATS 2012 International Conference in San Francisco.
"In this study, we found that prenatal exposures to airborne particles and the pollutant nitrogen dioxide adversely affect pulmonary function growth among asthmatic children between 6 and ...
4 acute mushroom poisonings in 2 weeks
2012-05-21
SAN DIEGO – On September 12, 2011, a Springfield, Virginia man arrived at MedStar Georgetown University Hospital (MGUH) in the early stages of liver failure. The man had mistakenly eaten poisonous mushrooms, handpicked from his yard. He would be the first of four patients in the course of two weeks to seek treatment at MGUH for mushroom (amanitin) poisoning. Their clinical course, management, and outcomes were presented today at Digestive Disease Week (DDW) in San Diego, the largest international gathering of physicians and researchers in the field of gastroenterology, ...
Statins prevent cancer in heart transplant recipients
2012-05-21
Statins prevent cancer and reduce death from all causes in heart transplant recipients. The findings were independent of cholesterol levels.
The research was presented at the Heart Failure Congress 2012, 19-22 May, in Belgrade, Serbia. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology.
Cancer is the leading cause of death late after heart transplantation. Skin cancer is particularly common, but solid organ cancers including colorectal cancer, prostate cancer and lymphoma also occur. The increased rate of ...
UW study: Sleep apnea associated with higher mortality from cancer
2012-05-21
Madison, Wis. and San Francisco — Sleep-disordered breathing (SDB), commonly known as sleep apnea, is associated with an increased risk of cancer mortality, according to a new study.
While previous studies have associated SDB with increased risks of hypertension, cardiovascular disease, depression, and early death, this is the first human study to link apnea with higher rate of cancer mortality. Lead author Dr. F. Javier Nieto, chair of the department of population health sciences at the UW School of Medicine and Public Health, says the study showed a nearly five times ...
First, do no harm: Study finds danger in standard treatment for a serious lung disease
2012-05-21
A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary fibrosis, according to the surprising results of a rigorous independent study.
The study, which will appear online May 20 in the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American Thoracic Society, was conducted by IPF Clinical Research Network, funded by the National Heart, Lung, and Blood Institute ...
Lab tests show arthritis drug effective against global parasite
2012-05-21
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
Based on these results, the team has received Orphan Drug Status for the drug, known as auranofin, from the U.S. Food and Drug Administration, and has applied for approval to start clinical trials to treat both amebiasis and the parasite Giardia in humans.
The findings, which showed that ...
Drug found for parasite that is major cause of death worldwide
2012-05-21
Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine has led to identification of an existing drug that is effective against Entamoeba histolytica. This parasite causes amebic dysentery and liver abscesses and results in the death of more than 70,000 people worldwide each year.
Using a high-throughput screen for drugs developed by the research team, they discovered that auranofin – a drug approved by the US Food and Drug Administration 25 years ago for rheumatoid arthritis – is very effective ...
Study examines treatments for relieving breathing difficulties among patients with lung effusions
2012-05-21
Helen E. Davies, M.D., of the University Hospital of Wales, Cardiff, and colleagues compared the effectiveness of treatments to relieve breathing difficulties among patients with malignant pleural effusion (presence of fluid in the pleural cavity [space between the outside of the lungs and the inside wall of the chest cavity], as a complication of malignant disease). The treatments compared were chest tube drainage and talc slurry for pleurodesis (a procedure in which the pleural space is obliterated) vs. indwelling pleural catheters (IPCs).
Malignant pleural effusion ...
Low-dose CT screening may benefit individuals at increased risk for lung cancer
2012-05-21
Peter B. Bach, M.D., of the Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted a systematic review to examine the evidence regarding the benefits and harms of low-dose computerized tomography (LDCT) screening for lung cancer, which is the leading cause of cancer death. "Most patients are diagnosed with advanced disease, resulting in a very low 5-year survival rate," the authors write. "Renewed enthusiasm for lung screening arose with the advent of LDCT imaging, which is able to identify smaller nodules than can chest radiographs."
For the review, ...
Study evaluates use of inhaled saline for young children with cystic fibrosis
2012-05-21
Margaret Rosenfeld, M.D., M.P.H., of Seattle Children's Hospital, and colleagues conducted a study to examine if hypertonic saline would reduce the rate of pulmonary exacerbations in children younger than 6 years of age with cystic fibrosis (CF). Inhaled hypertonic saline is recommended as therapy for patients 6 years or older with CF, but its efficacy has not been evaluated in patients younger than 6 years.
In the randomized trial, the active treatment group (n = 158) received 7 percent hypertonic saline and the control group (n = 163) received 0.9 percent isotonic saline, ...